Cabot (CBT) Research & Development (2009 - 2026)

Cabot (CBT) has 18 years of Research & Development data on file, last reported at $14.0 million in Q1 2026.

• Research & Development for Q1 2026 came in at $14.0 million, down 6.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $57.0 million (down 8.06% YoY), and the FY2025 annual result was $59.0 million, down 6.35% from the prior year.
• Research & Development grew to $14.0 million in Q1 2026 per CBT's latest filing, from $13.0 million in the prior quarter.
• Over five years, Research & Development peaked at $17.0 million in Q3 2024 and troughed at $13.0 million in Q4 2022.
• A 5-year average of $14.6 million and a median of $15.0 million in 2023 frame the typical range for Research & Development.
• The sharpest annual moves came in 2024 and 2025: Research & Development increased 21.43% in 2024, then decreased 11.76% in 2025.
• A 5-year view of Research & Development shows it stood at $13.0 million in 2022, then increased by 15.38% to $15.0 million in 2023, then decreased by 6.67% to $14.0 million in 2024, then fell by 7.14% to $13.0 million in 2025, then increased by 7.69% to $14.0 million in 2026.
• Business Quant data shows CBT's Research & Development at $14.0 million in Q1 2026, $13.0 million in Q4 2025, and $15.0 million in Q3 2025.